Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 13,442 | 10,577 | 11,396 | 8,466 |
| Gross Profit | 13,442 | 10,577 | 11,396 | 8,466 |
| Operating Expenses | 51,876 | 43,167 | 35,377 | 0 |
| Operating Income | -38,434 | -32,590 | -23,981 | 8,466 |
| Interest Expense | 549 | 998 | 711 | 0 |
| Other Income | 1,785 | 903 | 1,612 | 0 |
| Pre-tax Income | -37,198 | -32,685 | -23,080 | 8,466 |
| Net Income Continuous | -37,198 | -32,685 | -23,080 | -15,874 |
| Net Income | $-37,198 | $-32,685 | $-23,080 | $-15,874 |
| EPS Basic Total Ops | -11.28 | -102.52 | -79.48 | -67.07 |
| EPS Basic Continuous Ops | -11.28 | -102.55 | -79.48 | -67.06 |
| EPS Diluted Total Ops | -11.28 | -102.52 | -79.48 | -67.07 |
| EPS Diluted Continuous Ops | -11.28 | -102.55 | -79.48 | -67.06 |
| EBITDA(a) | $-35,158 | $-29,409 | $-21,132 | $8,466 |